Oppenheimer & CO Inc Orchard Therapeutics PLC Transaction History

Oppenheimer & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.36 - $0.49 $72 - $98	-200 Reduced 1.71%	11,500 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.69 $1,080 - $1,655	-2,400 Reduced 17.02%	11,700 $6,000
Q2 2022 Aug 08, 2022	BUY	$0.42 - $0.78 $1,050 - $1,950	2,500 Added 21.55%	14,100 $8,000
Q1 2022 May 12, 2022	BUY	$0.7 - $1.51 $8,119 - $17,516	11,600 New	11,600 $8,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.